Genprex, Inc. Soared
Tue, Oct 22, 2024 at 07:52 PM
Genprex, Inc. (GNPX:NASDAQ) jumped higher at $3.59, a gain of 137.7%. On Tue, Oct 22, 2024, GNPX:NASDAQ hit a New 2-Week High of $3.59. The stock got featured on our News Catalysts scanner on Wed, Oct 16, 2024 at 10:43 AM in the 'BIOTECH' category. From Tue, Oct 08, 2024, the stock recorded 50.00% Up Days and 45.45% Green Days
The stock spiked on Fri, May 31, 2024 at $4.09 with a volume of 3M+.
About Genprex, Inc. (GNPX:NASDAQ)
Genprex Inc is a clinical stage gene therapy company. It develops therapies that carry cancer-fighting genes. Its initial product candidate is Oncoprex.
Top 10 Gainers:
- Ensysce Biosciences Inc. (ENSC:NASDAQ), 161.65%
- Genprex, Inc. (GNPX:NASDAQ), 137.75%
- ENDRA Life Sciences Inc. (NDRA:NASDAQ), 90.22%
- Allakos Inc. (ALLK:NASDAQ), 57.04%
- Digital Brands Group Inc. (DBGI:NASDAQ), 49.63%
- Aptevo Therapeutics Inc. (APVO:NASDAQ), 48.01%
- Armlogi Holding Corp. (BTOC:NASDAQ), 47.7%
- F45 Training Holdings Inc. (FXLV:NYSE), 40.74%
- Phunware, Inc. (PHUN:NASDAQ), 38.41%
- noco-noco Inc. (NCNC:NASDAQ), 37.39%